Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03921658 · ClinicalTrials.gov registry record
The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 255
- Enrollment target
NCT03921658 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 255 participants.
The verdict
NCT03921658 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 255 participants
- Enrollment target
Study Summary
Cytomegalovirus (CMV), a widely prevalent virus in the general US population, has been shown to be associated with increased inflammation and mortality. Previous small pilot studies have demonstrated that latent CMV may be reactivated during chemotherapy in cancer patients, and may be associated with unfavorable cancer outcomes such as fatigue and increased mortality. The central research idea for this study, supported by previous preliminary data, is that CMV reactivation is an unrecognized complicating factor in the treatment of ovarian cancer that impacts patient outcomes. The overarching goals of this observational study are: * To assess how CMV infection is associated with ovarian cancer symptoms over the course of the disease and its treatment. * To describe the relationship between CMV reactivation in ovarian cancer patients, survival, fatigue, and other QOL outcomes, both cross-sectionally and longitudinally.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2019-10-22 |
| Est. Completion | 2024-04-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03921658
The ClinicalTrials.gov registry entry for NCT03921658 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03921658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03921658 about?
NCT03921658 is a clinical study titled "The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer". Cytomegalovirus (CMV), a widely prevalent virus in the general US population, has been shown to be associated with increased inflammation and mortality. Previous small pilot studies have demonstrated that latent CMV may be reactivated during chemotherapy in cancer patients, and may be associated wit...
What is the current status of trial NCT03921658?
This trial is currently completed. The enrollment target is 255 participants. The study started on 2019-10-22. Estimated completion is 2024-04-02.
Who is sponsoring clinical trial NCT03921658?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.